Neoleish

Authorised

This medicine is authorised for use in the European Union

bacterial DNA plasmid containing LACK gene from Leishmania infantum

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Neoleish
• Active substance:
  bacterial DNA plasmid containing LACK gene from Leishmania infantum
• International non-proprietary name (INN) or common name:
  bacterial DNA plasmid containing LACK gene from Leishmania infantum

Pharmacotherapeutic group

• Immunologicals for canidae
• Other immunologicals

Authorisation details

• EMA product number:
  EMEA/V/C/005538

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Neoleish

AdoptedReference Number: EMA/CVMP/858971/2022